CS logo
small CS logo
Sanofi-Aventis Administrative Office

Laval, Canada
Pharmaceutical company in Laval, Quebec
2905 Pl. Louis-R.-Renaud, Laval, QC H7V 0A3

About Sanofi-Aventis Administrative Office


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Sanofi-Aventis Administrative Office


During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office" #1 collaborator was "Bristol-Myers Squibb" with 7 trials as a collaborator, "Regeneron Pharmaceuticals" with 7 trials as a collaborator, "Cancer International Research Group (CIRG)" with 2 trials as a collaborator, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

Clinical Trials Conditions at Sanofi-Aventis Administrative Office


According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are "Atrial Fibrillation" (9 trials), "Ascites" (7 trials), "Liver Cirrhosis" (6 trials), "Sleep Initiation and Maintenance Disorders" (6 trials) and "Diabetes Mellitus, Type 2" (5 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.

Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office


Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (101 trials), "Device" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "placebo" (19 trials), "Semuloparin sodium" (5 trials), "Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Sanofi-Aventis Administrative Office


The vast majority of trials in "Sanofi-Aventis Administrative Office" are 96 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Clinical Trials Status at Sanofi-Aventis Administrative Office


Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Sanofi-Aventis Administrative Office, undefined suspended trials, and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".